Skip to main content

and
  1. No Access

    Article

    Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children

    A limited sampling strategy (LSS) for estimating the area under the curve (AUC) of the prolonged-release formulation of tacrolimus (tacrolimusPR) is not available in pediatric patients, although the method is of ...

    Wei Zhao, Anne Maisin, Véronique Baudouin in European Journal of Clinical Pharmacology (2013)

  2. No Access

    Article

    Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients

    TacrolimusPR is a new prolonged-release once-daily formulation of the calcineurin inhibitor tacrolimus, currently used in adult transplant patients. As there are no pharmacokinetic data available in pediatric kid...

    Wei Zhao, May Fakhoury, Véronique Baudouin in European Journal of Clinical Pharmacology (2013)

  3. No Access

    Article

    Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives

    Idiopathic nephrotic syndrome (INS) has been studied for decades in attempt to understand the physiopathological mechanisms explaining the disease. It is recognized as a multifactorial disease, with immunologi...

    Valéry Elie, May Fakhoury, Georges Deschênes, Evelyne Jacqz-Aigrain in Pediatric Nephrology (2012)

  4. No Access

    Article

    Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics

    Tacrolimus is known to potentially lead to adverse events in recipients with diarrhoea and/or calcium channel blocker (CCB) co-administration. We report a renal transplant recipient who suffered from severe ne...

    Sandrine Leroy, Arnaud Isapof, Sonia Fargue, May Fakhoury in Pediatric Nephrology (2010)

  5. Article

    A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia

    Christine Plard, Françoise Bressolle, May Fakhoury in Cancer Chemotherapy and Pharmacology (2007)

  6. No Access

    Article

    A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia

    The objectives of this study were to characterize the population pharmacokinetics of MTX in patients with acute lymphoblastic leukemia (ALL) with ages ranging from 2 to 16 years and to propose a limited sampli...

    Christine Piard, Françoise Bressolle, May Fakhoury in Cancer Chemotherapy and Pharmacology (2007)